Europe — EMA

Onureg (Azacitidine)

Azacitidine, the active ingredient in Onureg, is a nucleoside analogue presented as a 100 mg lyophilized powder for subcutaneous injection use.

Azacitidine

Request sourcing

Pack/s

What is Azacitidine?

Azacitidine, the active ingredient in Onureg, is a nucleoside analogue presented as a 100 mg lyophilized powder for subcutaneous injection use. It treats myelodysplastic syndromes and acute myeloid leukaemia in adult patients. GNH USA supplies Onureg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

GNH USA supplies Onureg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Azacitidine used for?

Onureg is a hypomethylating agent that is indicated for several - Myelodysplastic syndromes (MDS): improves ... - Acute ... - Chronic ...

What are the side effects of Azacitidine?

The …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →